AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
BSX vs REGN Fundamental Comparison
| Metric | BSX | REGN |
|---|---|---|
| Revenue | $20.1B | $14.3B |
| Net Income | $2.9B | $4.5B |
| Net Margin | 14.4% | 31.4% |
| ROE | 12.0% | 14.4% |
| ROA | 6.6% | 11.1% |
| Current Ratio | 1.62x | 4.13x |
| Debt/Equity | 0.46x | 0.06x |
| EPS | $1.94 | $41.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs REGN: Frequently Asked Questions
Is BSX or REGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. BSX is rated BUY (80% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.
How does BSX compare to REGN fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 12.0% vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 14.4% vs 31.4% respectively.
Which stock pays higher dividends, BSX or REGN?
BSX has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or REGN for long term?
For long-term investing, consider that BSX has BUY rating with 80% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs REGN, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.